JP2005527495A5 - - Google Patents

Download PDF

Info

Publication number
JP2005527495A5
JP2005527495A5 JP2003565430A JP2003565430A JP2005527495A5 JP 2005527495 A5 JP2005527495 A5 JP 2005527495A5 JP 2003565430 A JP2003565430 A JP 2003565430A JP 2003565430 A JP2003565430 A JP 2003565430A JP 2005527495 A5 JP2005527495 A5 JP 2005527495A5
Authority
JP
Japan
Prior art keywords
linker
ligand
och
acceptor moiety
oco
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003565430A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005527495A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/004023 external-priority patent/WO2003066004A2/en
Publication of JP2005527495A publication Critical patent/JP2005527495A/ja
Publication of JP2005527495A5 publication Critical patent/JP2005527495A5/ja
Pending legal-status Critical Current

Links

JP2003565430A 2002-02-08 2003-02-10 治療化合物 Pending JP2005527495A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35511102P 2002-02-08 2002-02-08
US36740002P 2002-03-25 2002-03-25
PCT/US2003/004023 WO2003066004A2 (en) 2002-02-08 2003-02-10 Therapeutic compounds

Publications (2)

Publication Number Publication Date
JP2005527495A JP2005527495A (ja) 2005-09-15
JP2005527495A5 true JP2005527495A5 (cg-RX-API-DMAC10.html) 2006-03-30

Family

ID=27737484

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003565430A Pending JP2005527495A (ja) 2002-02-08 2003-02-10 治療化合物

Country Status (6)

Country Link
US (2) US7439264B2 (cg-RX-API-DMAC10.html)
EP (1) EP1478356A4 (cg-RX-API-DMAC10.html)
JP (1) JP2005527495A (cg-RX-API-DMAC10.html)
AU (1) AU2003215150A1 (cg-RX-API-DMAC10.html)
CA (1) CA2476218A1 (cg-RX-API-DMAC10.html)
WO (1) WO2003066004A2 (cg-RX-API-DMAC10.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100143248A1 (en) * 1999-06-28 2010-06-10 President And Fellows Of Harvard College Methods for diagnosing and monitoring treatment of adhd by assessing the dopamine transporter level
WO2001068104A1 (en) * 2000-03-16 2001-09-20 The Mclean Hospital Corporation Compounds for the treatment of psychiatric or substance abuse disorders
US7550485B2 (en) * 2003-10-14 2009-06-23 Wyeth Substituted N-heterocycle derivatives and methods of their use
WO2005122767A1 (en) * 2004-06-10 2005-12-29 Mclean Hospital Corporation Pyrimidines, such as uridine, in treatments for patients with bipolar disorder
EP1765364A4 (en) * 2004-06-10 2010-09-22 Mclean Hospital Corp PYRIMIDINES, SUCH AS Z: B: CYTIDINE, IN THE TREATMENT OF PATIENTS WITH BIPOLAR DISORDER
US7947661B2 (en) * 2004-08-11 2011-05-24 The Mclean Hospital Corporation Compounds for the treatment of marihuana dependence, withdrawal, and usage
US20060069086A1 (en) * 2004-09-23 2006-03-30 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
WO2007100775A2 (en) * 2006-02-27 2007-09-07 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
GB2447949B (en) * 2007-03-29 2010-03-31 Renasci Consultancy Ltd A method for identifying a compound for treating a disorder or condition associated with dysfunction of monoamine neurotransmission
US20100041621A1 (en) * 2008-08-15 2010-02-18 Perry Renshaw Methods and compositions for improving cognitive performance
US8697888B2 (en) * 2012-01-06 2014-04-15 Vanderbilt University Substituted (1-(methylsulfonyl)azetidin-3-yl)(heterocycloalkyl)methanone analogs as antagonists of muscarinic acetylcholine M1 receptors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6531483B1 (en) 1990-08-09 2003-03-11 Research Triangle Institute Cocaine receptor binding ligands
US6241963B1 (en) 1995-10-19 2001-06-05 The Trustees Of The University Of Pennsylvania Dopamine and serotonin transporter ligands and imaging agents
US5948933A (en) 1997-07-11 1999-09-07 Organix, Inc. Tropane analogs and methods for inhibition of monoamine transport
AU1797700A (en) 1998-12-14 2000-07-03 Nuclear Receptor Research Limited Novel ligands of nuclear receptor
CA2721484A1 (en) 1999-05-12 2000-11-12 President And Fellows Of Harvard College Dopamine transporter imaging agents
US6479509B1 (en) 2000-05-22 2002-11-12 Research Triangle Institute Method of promoting smoking cessation
US6525206B1 (en) * 2000-10-17 2003-02-25 President And Fellows Of Harvard College Compounds with high monoamine transporter affinity
GB2380733A (en) 2001-10-11 2003-04-16 Bertha Kalifon Madras Non-amine tropane analogues

Similar Documents

Publication Publication Date Title
RU2500678C2 (ru) Замещенные хиноксалинового типа мостиковые пиперидиновые соединения и их применение
AR019478A1 (es) Ligandos derivados de piperidina de alta afinidad para el receptor de nociceptina orl-1, composiciones farmaceuticas que los comprenden y el uso de los mismos para la manufactura de medicamentos.
HUP0301427A2 (hu) Fotokemoterápiában alkalmazható fotoszenzitizáló, 5-aminolevulinsavészterek azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
AR063872A1 (es) Derivados de acetileno como inhibidores de estearoil coa desaturasa
JP2008525416A5 (cg-RX-API-DMAC10.html)
KR920012061A (ko) α-옥소아세트아미드 유도체
DE122007000065I2 (de) 3,3-diphenylpropylaminderivate
EP2754454A3 (en) Non-steroidal anti-inflammatory drug derivatives
KR880009020A (ko) 신규 치료법
KR930703305A (ko) 5-헤테로일 인돌 유도체
AR035479A1 (es) Derivados de eteres biarilicos y sus sales, composiciones farmaceuticas que los comprenden y procedimientos para el tratamiento de trastornos o afecciones
JP2010540638A5 (cg-RX-API-DMAC10.html)
WO2007099162A3 (fr) Derive de resveratrol a longue chaine hydroxylee utiles comme neurotrophiques
JP2006507220A5 (cg-RX-API-DMAC10.html)
JP2004527567A5 (cg-RX-API-DMAC10.html)
KR930700451A (ko) 항암제로서의 비스-나프탈이미드
RU2003134629A (ru) Соединения цефема
JP2005511833A5 (cg-RX-API-DMAC10.html)
ES397786A1 (es) Procedimiento para la obtencion de derivados piperidinicos.
BRPI0509390A (pt) derivados de 1-(1h-indol-1-il)-3-(4-metilpiperazin-1-il)-fenil propan-2-ol e compostos relacionados como moduladores da atividade da norepinefrina (ne) e da serotonina (5-th) e da reabsorção da monoamina para o tratamento de sintomas vasomotores (vms)
IE44739B1 (en) Adenine derivatives
CA2535511A1 (en) Compounds having thrombopoietin receptor agonism
WO2007079470A3 (en) Therapeutic amine-arylsulfonamide conjugate compounds
Pifferi et al. The cost benefit ratio of enantiomeric drugs
KR910000607A (ko) 새로운 에스테르